OR2K2 and frontotemporal dementia: In a more recent gene expression study encompassing healthy controls, advanced AD (Braak stage III–VI), frontotemporal dementia, and Huntington’s disease (GSE110226), OR2K2 was indeed found to be expressed in the CP.